Heart group issues new guidance on peripheral artery disease in hospital care
Peripheral artery diseasePart of a story we are following · 1 article · See every update
If you or someone you love has peripheral artery disease, the American Heart Association has just given hospital teams detailed guidance on how to care for it. The same guidance also says the disease is often missed.
In a scientific statement published in November 2026, the American Heart Association reviewed how peripheral artery disease (PAD) is handled when people are in the hospital. It says PAD is often misdiagnosed or diagnosed late, and that even after diagnosis it is undertreated. The statement describes what hospital teams need to know to care for people with PAD.
How the study worked
This is not a study with volunteers. It is a scientific statement, which means a panel of experts pulled together what is known and wrote down guidance for clinicians. It was published in Circulation on November 16, 2026. Because it is guidance and not a new trial, it does not give new statistics on how many people are affected.
What is peripheral artery disease?
PAD is a disease of the blood vessels. The statement describes it as linked to a higher chance of heart attack, stroke, other vascular disease, limb loss and a lower quality of life. It is also linked to a higher chance of death.
The good news is that the risks and the long-term care of PAD are well documented. Doctors know a lot about it. The gap is in using that knowledge consistently.
What they found
The statement makes a few plain points.
First, PAD is often misdiagnosed or diagnosed late. Even when it is diagnosed, people are often undertreated, both with medicines and with procedures that open or repair blood vessels.
Second, the risks are sharper when PAD shows up in someone who is in the hospital for something else. The statement says the risks are “acutely magnified” in that situation. A person might be there for a heart attack, a serious heart problem or a heart valve condition.
Third, PAD changes how some treatments should be done. Procedures that need access to blood vessels, such as those used for heart attack, cardiogenic shock or valve disease, need special consideration in people with PAD. So do procedures to treat the PAD itself.
Finally, the statement says hospital teams need to be familiar with mechanical circulatory support, which is a device that supports the heart’s pumping, and how it is placed in people with PAD. They also need to know how to manage a recent vascular procedure, whether it was done through a catheter or with surgery. The statement calls this knowledge essential for appropriate care in the acute care setting, meaning the hospital settings where people arrive with urgent problems.
What does this mean for you?
The statement puts this topic in front of hospital teams and spells out what they need to know. It is also a little sobering that PAD is so often missed or treated too lightly.
The statement is written for clinicians, so it does not change what you need to do day to day. It does show that PAD is something care teams are being asked to look for and take seriously, especially when someone is hospitalized.
What you can do today
Write down your health conditions in one place, including PAD if you have been diagnosed with it, along with your medicines and any vascular procedures you have had. Keep the list in your wallet or on your phone.
For clinicians and researchers
Design: American Heart Association scientific statement (systematic-review type) on diagnosis and management of peripheral artery disease in acute care settings, covering common presentations and emergencies. The abstract gives no n, follow-up or comparator.
Main result: No effect size reported. The statement notes PAD is associated with increased risk of mortality, myocardial infarction, stroke, other vascular disease, limb loss, and reduced quality of life, with risks magnified in hospitalized patients.
Main limitation: The abstract reports no search method, study count or quantitative synthesis; as a scientific statement, recommendations rest on available evidence and expert consensus, not a new pooled analysis.
Open question: Not stated in the abstract; the text points to underdiagnosis and undertreatment of PAD, and to special considerations for vascular access and mechanical circulatory support, as areas needing attention.
Cite this article
Mongevity Desk. Heart group issues new guidance on peripheral artery disease in hospital care. Mongevity. Published November 21, 2026. Accessed November 22, 2026. https://mongevity.science/heart/2026/11/peripheral-artery-disease-hospital-care-guidance/Mongevity Desk. Heart group issues new guidance on peripheral artery disease in hospital care [Internet]. Mongevity; 2026 Nov 21 cited 2026 Nov 22]. Available from: https://mongevity.science/heart/2026/11/peripheral-artery-disease-hospital-care-guidance/Mongevity Desk. (2026, November 21). Heart group issues new guidance on peripheral artery disease in hospital care. Mongevity. https://mongevity.science/heart/2026/11/peripheral-artery-disease-hospital-care-guidance/
<a href="https://mongevity.science/heart/2026/11/peripheral-artery-disease-hospital-care-guidance/">Heart group issues new guidance on peripheral artery disease in hospital care</a>
Free to share or quote with credit and a link.
Questions and answers
- What is peripheral artery disease?
- It is a disease of the blood vessels. The American Heart Association statement links it to a higher chance of heart attack, stroke, limb loss and lower quality of life.
- Is peripheral artery disease often missed?
- Yes. The statement says people with PAD are often misdiagnosed or diagnosed late, and are often undertreated even after diagnosis.
- Why does PAD matter in the hospital?
- The statement says the risks are sharper when PAD exists in someone hospitalized for another heart or medical condition, and some procedures need special care.
- Who is this guidance written for?
- It is written for clinicians who care for people in acute care settings. It was published in Circulation on November 16, 2026.